Steven R. Grossman

10.3k citations

102 papers · 7.8k indexed · 2 hit papers · h-index 45

Oncology top 0.5%
- Cancer-related Molecular Pathways 33
- Pancreatic and Hepatic Oncology Research 8
Molecular Biology top 1%
- Cancer-related gene regulation 22
- Kruppel-like factors research 21
- Ubiquitin and proteasome pathways 17
- Epigenetics and DNA Methylation 9
Cancer Research top 2%
Behavioral Neuroscience top 2%
Genetics top 2%
- Genetic Syndromes and Imprinting 7
Biotechnology
- Cancer Research and Treatments 7

Co-authors: David M. Livingston Laimonis A. Laimins James A. DeCaprio Doron Ginsberg Nancy L. Lill Andrew L. Kung Dingding Shi Chrystelle Brignone
Cited by: Oncology Molecular Biology Cancer Research
Journals: Nature (3 papers)Science (1 paper)Cell (2 papers)
Partner nations: United States Canada Germany

In The Last Decade

Steven R. Grossman

101 papers receiving 7.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Steven R. Grossman

Since Specialization

Citations

This map shows the geographic impact of Steven R. Grossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven R. Grossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven R. Grossman more than expected).

Fields of papers citing papers by Steven R. Grossman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven R. Grossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven R. Grossman. The network helps show where Steven R. Grossman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven R. Grossman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven R. Grossman Line = papers co-authored together Steven R. Grossman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Oncogenic Mutant p53 Sensitizes Non–Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress–Dependent Induction of Mitochondrial Apoptosis Cancer Research Communications ·Kranthi Kumar Chougoni,Victoria Neely,Boxiao Ding,Eziafa Oduah,Vianna T. Lam,Bin Hu,Jennifer E. Koblinski,Bradford E. Windle,Swati Palit Deb,Sumitra Deb,Jorge J. Nieva,Senthil K. Radhakrishnan,Hisashi Harada,Steven R. Grossman	2024	3
2	Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis Cancer Letters ·Tiantian Zhang,Sha Li,Yingcai Adrian Tan,Xiang Chen,Cheryl Zhang,Zhengming Chen,Bikash Mishra,Joseph Na,Soyoung Choi,Sandra J. Shin,Priyadarshan K. Damle,Kranthi Kumar Chougoni,Steven R. Grossman,Dunrui Wang,Xuejun Jiang,Yi Li,Erika Hissong,Yao‐Tseng Chen,Jenny Xiang,Yi‐Chieh Nancy Du	2024	0
3	ADCC's Improving Goal Concordant Care Initiative: Implementing Primary Palliative Care Principles Journal of Pain and Symptom Management ·Elizabeth T. Loggers,Amy A. Case,Marcin Chwistek,William Dale,Marvin Omar Delgado-Guay,Stephen B. Edge,Steven R. Grossman,Jillian Gustin,Judith E. Nelson,Sahana Rajasekhara,Akhila Reddy,James A. Tulsky,Finly Zachariah,Kristen K. McNiff	2023	4
4	Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promising Novel Therapy for Pancreatic Cancer Cancer Research Communications ·M. Michael Dcona,Kranthi Kumar Chougoni,Diana T. Dcona,Jacqueline L. West,Sahib J. Singh,Keith C. Ellis,Steven R. Grossman	2023	2
5	Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma Oncogenesis ·Kranthi Kumar Chougoni,Haemin Park,Priyadarshan K. Damle,Travis Mason,Bo Cheng,M. Michael Dcona,Barbara Szomju,Mikhail G. Dozmorov,Michael O. Idowu,Steven R. Grossman	2023	1
6	Cell competition in intratumoral and tumor microenvironment interactions The EMBO Journal ·Taylor M. Parker,Kartik Gupta,Antonio Palma,Michail Yekelchyk,Paul B. Fisher,Steven R. Grossman,Kyoung‐Jae Won,Esha Madan,Eduardo Moreno,Rajan Gogna	2021	62
7	Extraction of high-quality RNA from mouse pancreatic tumors MethodsX ·Kranthi Kumar Chougoni,Steven R. Grossman	2020	4
8	Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer Advances in Radiation Oncology ·Emma C. Fields,Brian Kaplan,Jeremy Karlin,Jennifer L. Myers,Nitai D. Mukhopadhyay,Xiaoyan Deng,Heidi Sankala,Steven R. Grossman,Khalid Matin	2019	3
9	Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells Molecular Oncology ·Catherine A. Vaughan,Shilpa Singh,Steven R. Grossman,Brad E. Windle,Swati Palit Deb,Sumitra Deb,(unknown),(unknown)	2017	14
10	Clinic Blood Pressure Underestimates Ambulatory Blood Pressure in an Untreated Employer-Based US Population Circulation ·Joseph E. Schwartz,Matthew M. Burg,Daichi Shimbo,Joan E. Broderick,Arthur A. Stone,Joji Ishikawa,Richard P. Sloan,Tyla Yurgel,Steven R. Grossman,Thomas G. Pickering	2016	60
11	Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination Molecular Cancer Research ·Rebecca A. Frum,Ian M. Love,Priyadarshan K. Damle,Nitai D. Mukhopadhyay,Swati Palit Deb,Sumitra Deb,Steven R. Grossman	2016	14
12	Pancreatic Cancer–Specific Cell Death Induced In Vivo by Cytoplasmic-Delivered Polyinosine–Polycytidylic Acid Cancer Research ·Praveen Bhoopathi,Bridget A. Quinn,Qin Gui,Xue‐Ning Shen,Steven R. Grossman,Swadesh K. Das,Devanand Sarkar,Paul B. Fisher,Luni Emdad	2014	34
13	The ARF Tumor Suppressor Inhibits Tumor Cell Colonization Independent of p53 in a Novel Mouse Model of Pancreatic Ductal Adenocarcinoma Metastasis Molecular Cancer Research ·Viviane P. Muniz,J. Matthew Barnes,Seema Paliwal,Xuefeng Zhang,Xiaoyun Tang,Songhai Chen,K. D. Zamba,Joseph J. Cullen,David K. Meyerholz,Shari Meyers,J. Nathan Davis,Steven R. Grossman,Michael D. Henry,Dawn E. Quelle	2011	24
14	Mdm2 facilitates the association of p53 with the proteasome Proceedings of the National Academy of Sciences ·R. Kulikov,Justine Letienne,Manjit Kaur,Steven R. Grossman,Janine Arts,Christine Blattner	2010	62
15	p19Arf Inhibits the Invasion of Hepatocellular Carcinoma Cells by Binding to C-terminal Binding Protein Cancer Research ·Ya‐Wen Chen,Seema Paliwal,Kyle Draheim,Steven R. Grossman,Brian C. Lewis	2008	48
16	Spontaneous Expression of Embryonic Factors and p53 Point Mutations in Aged Mesenchymal Stem Cells: A Model of Age-Related Tumorigenesis In Mice Cancer Research ·Hanchen Li,Xueli Fan,Ramesh C. Kovi,Yunju Jo,Brian Moquin,Richard F. Konz,Calin Stoicov,Evelyn A. Kurt‐Jones,Steven R. Grossman,Steven Lyle,Arlin B. Rogers,Marshall H. Montrose,JeanMarie Houghton	2007	155
17	Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features Comprehensive Psychiatry ·Tom Craig,Steven R. Grossman,Evelyn J. Bromet,Laura J. Fochtmann,Gabrielle A. Carlson	2007	7
18	A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway Oncogene ·Chrystelle Brignone,Kathleen Bradley,Alexei F. Kisselev,Steven R. Grossman	2004	55
19	Cells Degrade a Novel Inhibitor of Differentiation with E1A-Like Properties upon Exiting the Cell Cycle Molecular and Cellular Biology ·Satoshi Miyake,William R. Sellers,Michal Safran,Xiaotong Li,Wenqing Zhao,Steven R. Grossman,Jianmin Gan,James A. DeCaprio,Peter D. Adams,William G. Kaelin	2000	94
20	BVRT - scoring system and time delay in the differentiation of lateralized hemispheric damage Eli Vakil,Haya Blachstein,P Sheleff,Steven R. Grossman	1989	5

About Steven R. Grossman

Steven R. Grossman is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 102 papers that have together received 7.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (33 papers), Cancer-related gene regulation (22 papers), Kruppel-like factors research (21 papers), Ubiquitin and proteasome pathways (17 papers), Epigenetics and DNA Methylation (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Genetic Syndromes and Imprinting (7 papers) and Cancer Research and Treatments (7 papers). The work is most often cited by research in Oncology (2.9k citations), Molecular Biology (4.8k citations) and Cancer Research (908 citations). Steven R. Grossman has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include David M. Livingston, Laimonis A. Laimins, James A. DeCaprio, Doron Ginsberg, Nancy L. Lill, Andrew L. Kung, Dingding Shi, Chrystelle Brignone, Arthur A. Stone and Joseph E. Schwartz. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact